Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,255 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,255 Papers indexed
1,440 Papers AI scored
40,255 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-09 10:15 AM
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40255 results
D
Painful scoliosis in an adolescent: a diagnostic dilemma.
PMID 39608833 Published: 2024-11-27 Ingested: 2026-08-02 12:02 AM BMJ case reports
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
Tricuspid mass-curious case of Li-Fraumeni syndrome: A letter to the editor.
PMID 39600484 Published: 2024-11-26 Ingested: 2026-08-02 12:02 AM World journal of clinical cases
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
Polycyclic aromatic hydrocarbons within the vicinity of a scrap-iron smelting plant: indoor-outdoor and seasonal pattern, source, and exposure risk assessment.
PMID 39561051 Published: 2024-11-19 Ingested: 2026-08-02 12:02 AM International journal of environmental health research
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
Recurrent Solitary Neurofibroma Involving the Proximal Lacrimal Drainage System.
PMID 39560109 Published: 2024-11-19 Ingested: 2026-08-02 12:02 AM Ophthalmic plastic and reconstructive surgery
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
Meet the author: Jayne Hehir-Kwa.
PMID 39541935 Published: 2024-11-13 Ingested: 2026-08-02 12:02 AM Cell genomics
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
Update on Pediatric Surveillance Recommendations for PTEN Hamartoma Tumor Syndrome, DICER1-Related Tumor Predisposition, and Tuberous Sclerosis Complex.
PMID 39540884 Published: 2025-01-17 Ingested: 2026-08-02 12:03 AM Clinical cancer research : an official journal of the American Association for Cancer Research
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
Implementing Screening for Eating Disorders in Adolescents and Young Adults with a History of Cancer.
PMID 39530157 Published: 2024-11-12 Ingested: 2026-08-02 12:02 AM Journal of adolescent and young adult oncology
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
Polycystic Ovary Syndrome in Adolescents.
PMID 39510738 Published: 2024-09-20 Ingested: 2026-08-02 12:02 AM Obstetrics and gynecology clinics of North America
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
The oral microbiome of children in health and disease-a literature review.
PMID 39502321 Published: 2024-10-22 Ingested: 2026-08-02 12:02 AM Frontiers in oral health
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

D
What is new in fibroblastic/myofibroblastic tumors in children.
PMID 39499317 Published: 2024-11-05 Ingested: 2026-08-02 12:02 AM Virchows Archiv : an international journal of pathology
AI -
Standard 53.0
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 53.0/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 10.0; sample size: 20.0; recency: 90.0; abstract quality: 65.0.

Previous
Page 2791 of 3355
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic